USD 7.12
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 9.6 Billion CNY | 9.0% |
2022 | 8.81 Billion CNY | 72.91% |
2021 | 5.09 Billion CNY | 72.19% |
2020 | 2.96 Billion CNY | 59.62% |
2019 | 1.85 Billion CNY | -17.96% |
2018 | 2.26 Billion CNY | 84.22% |
2017 | 1.22 Billion CNY | 25.86% |
2016 | 974.98 Million CNY | 179.39% |
2015 | 348.96 Million CNY | -24.38% |
2014 | 461.5 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 1.94 Billion CNY | 26.91% |
2024 Q3 | 2.29 Billion CNY | -0.2% |
2024 Q2 | 2.29 Billion CNY | 18.3% |
2023 Q2 | 3.14 Billion CNY | 45.06% |
2023 FY | 9.6 Billion CNY | 9.0% |
2023 Q1 | 2.16 Billion CNY | 51.0% |
2023 Q3 | 2.76 Billion CNY | -12.14% |
2023 Q4 | 1.53 Billion CNY | -44.62% |
2022 Q3 | 2.74 Billion CNY | -8.37% |
2022 Q1 | 1.64 Billion CNY | 7.04% |
2022 FY | 8.81 Billion CNY | 72.91% |
2022 Q2 | 2.99 Billion CNY | 82.16% |
2022 Q4 | 1.43 Billion CNY | -47.64% |
2021 FY | 5.09 Billion CNY | 72.19% |
2021 Q4 | 1.53 Billion CNY | 73.02% |
2021 Q2 | 1.17 Billion CNY | -21.64% |
2021 Q1 | 1.49 Billion CNY | 153.4% |
2021 Q3 | 887.12 Million CNY | -24.52% |
2020 Q2 | 1.41 Billion CNY | 366.64% |
2020 Q1 | 303.04 Million CNY | 238.96% |
2020 Q3 | 651.2 Million CNY | -53.95% |
2020 FY | 2.96 Billion CNY | 59.62% |
2020 Q4 | 591.87 Million CNY | -9.11% |
2019 Q4 | 89.4 Million CNY | -87.38% |
2019 Q2 | 670.28 Million CNY | 73.43% |
2019 Q1 | 386.47 Million CNY | 16.36% |
2019 FY | 1.85 Billion CNY | -17.96% |
2019 Q3 | 708.38 Million CNY | 5.68% |
2018 Q1 | 290.65 Million CNY | 77.17% |
2018 FY | 2.26 Billion CNY | 84.22% |
2018 Q2 | 981.23 Million CNY | 237.59% |
2018 Q4 | 332.14 Million CNY | -49.4% |
2018 Q3 | 656.47 Million CNY | -33.1% |
2017 FY | 1.22 Billion CNY | 25.86% |
2017 Q4 | 164.05 Million CNY | -48.83% |
2017 Q3 | 320.59 Million CNY | -20.95% |
2017 Q1 | 336.86 Million CNY | 0.0% |
2017 Q2 | 405.57 Million CNY | 20.4% |
2016 FY | 974.98 Million CNY | 179.39% |
2015 FY | 348.96 Million CNY | -24.38% |
2014 FY | 461.5 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
American Bio Medica Corporation | -1.41 Million USD | 681429.726% |
Arrayit Corporation | -3.31 Million USD | 289844.436% |
Atlantic International Corp. | -5.62 Million USD | 170808.019% |
Biocept, Inc. | -32.08 Million USD | 30039.693% |
Bioqual, Inc. | 483.48 Thousand USD | -1986896.208% |
CardioGenics Holdings Inc | -1.91 Million USD | 501411.32% |
DermTech, Inc. | -100.88 Million USD | 9622.192% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | -374.443% |
HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 44587.068% |
iMD Companies, Inc. | -200.63 Thousand USD | 4788248.256% |
IDenta Corp. | 14.64 Thousand USD | -65601847.111% |
Interpace Biosciences, Inc. | 802 Thousand USD | -1197749.019% |
Integrative Health Technologies, Inc. | 38.68 Thousand USD | -24830598.997% |
InVitro International | 1553.00 USD | -618592890.019% |
Lumos Diagnostics Holdings Limited | -8.59 Million USD | 111910.395% |
Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 16531537.801% |
Medical Imaging Corp. | -3.02 Million USD | 317886.069% |
NovelStem International Corp. | -4.18 Million USD | 229525.862% |
Optigenex Inc. | -2.89 Million USD | 331623.285% |
PharmChem, Inc. | 845.1 Thousand USD | -1136656.171% |
Proteome Sciences plc | -2.44 Million USD | 393335.74% |
Response Genetics, Inc | -20.18 Million USD | 47695.864% |
Rennova Health, Inc. | -3.29 Million USD | 291827.564% |
RushNet, Inc. | -607.02 Thousand USD | 1582687.481% |
ScreenPro Security Inc. | -2.24 Million USD | 427300.734% |
Stella Diagnostics Inc. | -5.7 Million USD | 168420.111% |
StageZero Life Sciences Ltd. | -11.41 Million USD | 84256.251% |
Todos Medical Ltd. | -24.99 Million USD | 38536.221% |